Control of Nitrosamine Impurities in Human Drugs: FDA Guidance for Industry
Guidance recommends steps manufacturers of active pharmaceutical ingredients and drug products should take to detect and prevent unacceptable levels of nitrosamine impurities in pharmaceutical products. It also describes conditions that may introduce nitrosamine impurities.
Source:
US Food and Drug Administration